ST
VRTX icon

Spinnaker Trust’s Vertex Pharmaceuticals VRTX Stock Holding History

Spinnaker Trust’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$651K Hold
1,458
– – 0.04% 180
2025
Q4 		$661K Sell
1,458
-47
-3% -$20.3K 0.04% 178
2025
Q3 		$589K Hold
1,505
– – 0.03% 190
2025
Q2 		$670K Buy
1,505
+260
+21% +$120K 0.04% 180
2025
Q1 		$604K Buy
1,245
+10
+0.8% +$4.66K 0.04% 185
2024
Q4 		$497K Buy
1,235
+25
+2% +$11.6K 0.03% 196
2024
Q3 		$563K Hold
1,210
– – 0.03% 187
2024
Q2 		$567K Hold
1,210
– – 0.04% 186
2024
Q1 		$506K Hold
1,210
– – 0.03% 193
2023
Q4 		$492K Hold
1,210
– – 0.03% 188
2023
Q3 		$421K Hold
1,210
– – 0.03% 192
2023
Q2 		$426K Hold
1,210
– – 0.03% 186
2023
Q1 		$381K Hold
1,210
– – 0.03% 190
2022
Q4 		$349K Hold
1,210
– – 0.03% 215
2022
Q3 		$350K Hold
1,210
– – 0.03% 206
2022
Q2 		$341K Sell
1,210
-20
-2% -$5.35K 0.03% 218
2022
Q1 		$321K Hold
1,230
– – 0.02% 227
2021
Q4 		$270K Hold
1,230
– – 0.02% 248
2021
Q3 		$223K Sell
1,230
-1,400
-53% -$273K 0.02% 256
2021
Q2 		$530K Hold
2,630
– – 0.04% 183
2021
Q1 		$565K Hold
2,630
– – 0.04% 161
2020
Q4 		$621K Buy
2,630
+1,400
+114% +$321K 0.05% 149
2020
Q3 		$334K Buy
1,230
+120
+11% +$33.1K 0.03% 181
2020
Q2 		$322K Hold
1,110
– – 0.03% 183
2020
Q1 		$264K Hold
1,110
– – 0.03% 201
2019
Q4 		$243K Buy
+1,110
New +$225K 0.02% 227
2019
Q3 		– Sell
-1,110
Closed -$203K – 242
2019
Q2 		$203K Sell
1,110
-20
-2% -$3.5K 0.02% 227
2019
Q1 		$207K Buy
+1,130
New +$209K 0.02% 229
2018
Q4 		– Sell
-1,130
Closed -$217K – 235
2018
Q3 		$217K Buy
+1,130
New +$201K 0.02% 216

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Spinnaker Trust's VRTX Position: Q1 2026 in Review

Spinnaker Trust held its Vertex Pharmaceuticals (VRTX) position steady in Q1 2026 at 1,458 shares worth $651K. The position accounts for 0.04% of the portfolio, ranked #180.

Spinnaker Trust first reported a position in VRTX in Q3 2018 and has held it in 29 quarters since. The position peaked at $670K in Q2 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Spinnaker Trust held 1,458 shares of Vertex Pharmaceuticals worth $651K as of Q1 2026.
  • Spinnaker Trust left its Vertex Pharmaceuticals share count unchanged in Q1 2026.
  • Vertex Pharmaceuticals made up 0.04% of Spinnaker Trust's portfolio in Q1 2026, its #180 holding.
  • Spinnaker Trust first reported a position in Vertex Pharmaceuticals in Q3 2018 and has held it in 29 quarters since.
  • Spinnaker Trust's Vertex Pharmaceuticals position peaked at $670K in Q2 2025.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Spinnaker Trust's 13F filing for Q1 2026, filed 23 Apr 2026.